Kim, D.Y.; Kim, S.R.; Jung, U.J.
Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice. Int. J. Mol. Sci. 2020, 21, 1870.
https://doi.org/10.3390/ijms21051870
AMA Style
Kim DY, Kim SR, Jung UJ.
Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice. International Journal of Molecular Sciences. 2020; 21(5):1870.
https://doi.org/10.3390/ijms21051870
Chicago/Turabian Style
Kim, Do Yeon, Sang Ryong Kim, and Un Ju Jung.
2020. "Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice" International Journal of Molecular Sciences 21, no. 5: 1870.
https://doi.org/10.3390/ijms21051870
APA Style
Kim, D. Y., Kim, S. R., & Jung, U. J.
(2020). Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice. International Journal of Molecular Sciences, 21(5), 1870.
https://doi.org/10.3390/ijms21051870